OTCs Should Be Addressed In Medicare Formulary Requirements – Blues
This article was originally published in The Tan Sheet
Executive Summary
U.S. Pharmacopeia should reduce the requirement that Medicare formularies include at least two drugs per class where OTC options are available, the BlueCross BlueShield Association said at a public meeting on USP's draft model guidelines
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning